Other languages Third Harmonic Bio, Inc.

Equities

THRD

US88427A1079

Real-time Estimate Cboe BZX Other stock markets 02:36:54 2024-07-16 pm EDT			5-day change	1st Jan Change
12.98 ^USD	+0.19%		+6.50%	+16.50%

Jun. 18	Stifel Initiates Third Harmonic Bio With Buy Rating, $23 Price Target	MT
Jun. 07	Third Harmonic Bio, Inc. Announce Resignation of Rob Perez as a Class I Director of the Board, and as Chairperson of the Nominating and Governance Committee of the Board and A Member of the Audit Committee of the Board	CI

Other languages

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Third Harmonic Bio, Inc. Announce Resignation of Rob Perez as a Class I Director of the Board, and as Chairperson of the Nominating and Governance Committee of the Board and A Member of the Audit Committee of the Board	Jun. 07
Third Harmonic Bio Insider Sold Shares Worth $331,066, According to a Recent SEC Filing	May. 20
Third Harmonic Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 15
Third Harmonic Bio, Inc. Announces the Appointment and Promotion of Key Executive Leaders to the Organization	May. 15
Third Harmonic Bio, Inc. Appoints Geoff Mcdonough to Its Board of Directors	Mar. 28
Third Harmonic Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 26
Third Harmonic Bio Names Christopher Murphy as Chief Financial, Business Officer	Jan. 04
Third Harmonic Bio, Inc. Appoints Christopher Murphy as Chief Business Officer	Jan. 04
Third Harmonic Bio, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 09
Third Harmonic Bio, Inc. Announces the Transition of Adrian S. Ray from Chief Scientific Officer to Scientific Advisor, Effective November 1, 2023	23-10-31
Third Harmonic Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10
Third Harmonic Bio, Inc Announces Next-Generation Oral KIT Inhibitor Product Candidate THB335	23-07-25
Third Harmonic Bio, Inc. Ratifies the Appointment of Deloitte & Touche LLP as the Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2023	23-06-08
Third Harmonic Bio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-11
Third Harmonic Bio, Inc. Announces Resignation of Shao-Lee Lin as Class II Director and Chairperson of the Nominating and Governance Committee of the Board	23-01-19
Top Midday Decliners	22-12-15
Sector Update: Health Care Stocks Sinking with Broader Thursday Markets	22-12-15
Sector Update: Health Care	22-12-15
Third Harmonic Bio Halts Phase 1b Trial of Proposed Treatment for Inflammatory Skin Condition; Shares Decline	22-12-15
Weaker-Than-Expected Retail Sales, Hawkish Fed Send US Stock Futures Sharply Lower	22-12-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Third Harmonic Bio, Inc.

Equities

THRD

US88427A1079

Other languages

Filters